Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Free Cash Flow (2016 - 2026)

Cartesian Therapeutics (RNAC) has disclosed Free Cash Flow for 12 consecutive years, with -$22.2 million as the latest value for Q1 2026.

  • For Q1 2026, Free Cash Flow rose 6.13% year-over-year to -$22.2 million; the TTM value through Mar 2026 reached -$77.9 million, down 92.49%, while the annual FY2025 figure was -$79.4 million, 142.3% down from the prior year.
  • Free Cash Flow hit -$22.2 million in Q1 2026 for Cartesian Therapeutics, down from -$18.2 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $7.5 million in Q3 2024 and bottomed at -$23.6 million in Q1 2025.
  • Average Free Cash Flow over 5 years is -$12.9 million, with a median of -$12.7 million recorded in 2022.
  • Year-over-year, Free Cash Flow skyrocketed 181.99% in 2024 and then crashed 365.27% in 2025.
  • Cartesian Therapeutics' Free Cash Flow stood at -$12.1 million in 2022, then plummeted by 93.61% to -$23.3 million in 2023, then skyrocketed by 66.99% to -$7.7 million in 2024, then crashed by 136.2% to -$18.2 million in 2025, then decreased by 21.92% to -$22.2 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$22.2 million, -$18.2 million, and -$19.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.